Management of patients with moderate alcoholic liver disease.
作者信息
Crittenden Neil Edward, McClain Craig
机构信息
Department of Medicine and Pharmacology & Toxicology, University of Louisville, Louisville, KY.
Departments of Medicine and Pharmacology & Toxicology, University of Louisville, Louisville, KY.
出版信息
Clin Liver Dis (Hoboken). 2013 Apr 24;2(2):76-79. doi: 10.1002/cld.190. eCollection 2013 Apr.
Abstract
摘要
相似文献
1
Management of patients with moderate alcoholic liver disease.中度酒精性肝病患者的管理
Clin Liver Dis (Hoboken). 2013 Apr 24;2(2):76-79. doi: 10.1002/cld.190. eCollection 2013 Apr.
2
Controversies in the management of alcoholic liver disease.酒精性肝病管理中的争议
Mt Sinai J Med. 2009 Oct;76(5):484-98. doi: 10.1002/msj.20135.
3
Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease.酒精性肝病患者的精神疾病发病模式与酒精依赖情况
Dig Dis Sci. 1988 Apr;33(4):443-8. doi: 10.1007/BF01536029.
4
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease.他汀类药物治疗非酒精性脂肪性肝病的疗效及安全性。
Dig Liver Dis. 2015 Jan;47(1):4-11. doi: 10.1016/j.dld.2014.07.170. Epub 2014 Sep 16.
5
Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.非酒精性脂肪性肝病与糖耐量正常的受试者动脉僵硬度增加有关，但与糖尿病前期和糖尿病患者无关。
Diab Vasc Dis Res. 2015 Sep;12(5):359-65. doi: 10.1177/1479164115585009. Epub 2015 May 25.
6
[New suggestions for the management of alcoholic liver diseases].[酒精性肝病管理的新建议]
Acta Gastroenterol Latinoam. 1995;25(2):73-84.
7
Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease.
J Hepatol. 1997 Jan;26(1):55-61. doi: 10.1016/s0168-8278(97)80009-8.
8
Review article: current management of alcoholic liver disease.综述文章：酒精性肝病的当前管理
Aliment Pharmacol Ther. 2004 Apr 1;19(7):707-14. doi: 10.1111/j.1365-2036.2004.01881.x.
9
A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit.
J Hepatol. 1997 Dec;27(6):1003-8. doi: 10.1016/s0168-8278(97)80143-2.
10
Glutathione-S-transferase GST M1 "null" genotype and the risk of alcoholic liver disease.谷胱甘肽-S-转移酶GST M1“无效”基因型与酒精性肝病风险
Alcohol Clin Exp Res. 1996 Nov;20(8):1340-5. doi: 10.1111/j.1530-0277.1996.tb01132.x.
引用本文的文献
1
Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise.酒精性肝病的流行病学现状：全球负担、研究趋势和治疗前景。
Gene Expr. 2020 Nov 11;20(2):105-118. doi: 10.3727/105221620X15952664091823. Epub 2020 Jul 20.
2
Probiotics for people with hepatic encephalopathy.用于肝性脑病患者的益生菌。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD008716. doi: 10.1002/14651858.CD008716.pub3.
本文引用的文献
1
Probiotics in the treatment of the liver diseases.益生菌治疗肝脏疾病。
J Am Coll Nutr. 2012 Feb;31(1):14-23. doi: 10.1080/07315724.2012.10720004.
2
S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.S-腺苷甲硫氨酸（SAMe）治疗肝脏疾病：当前证据和临床应用的综述。
J Hepatol. 2012 Nov;57(5):1097-109. doi: 10.1016/j.jhep.2012.04.041. Epub 2012 May 30.
3
EASL clinical practical guidelines: management of alcoholic liver disease.欧洲肝脏研究学会临床实践指南：酒精性肝病的管理
J Hepatol. 2012 Aug;57(2):399-420. doi: 10.1016/j.jhep.2012.04.004. Epub 2012 May 26.
4
The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease.膳食脂肪的类型可调节酒精性肝病小鼠模型中肠道紧密连接的完整性、肠道通透性和肝脏 toll 样受体的表达。
Alcohol Clin Exp Res. 2012 May;36(5):835-46. doi: 10.1111/j.1530-0277.2011.01673.x. Epub 2011 Dec 7.
5
Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence.定义巴氯芬治疗酒精依赖的作用：证据的系统评价。
CNS Drugs. 2012 Jan 1;26(1):69-78. doi: 10.2165/11597320-000000000-00000.
6
Nutritional evaluation of alcoholic inpatients admitted for alcohol detoxification.酒精戒断住院患者的营养评估。
Alcohol Alcohol. 2011 Sep-Oct;46(5):558-60. doi: 10.1093/alcalc/agr062. Epub 2011 May 31.
7
Alcoholic liver disease and malnutrition.酒精性肝病与营养不良。
Alcohol Clin Exp Res. 2011 May;35(5):815-20. doi: 10.1111/j.1530-0277.2010.01405.x. Epub 2011 Feb 1.
8
Management of alcoholic liver disease.酒精性肝病的管理
Clin Liver Dis. 2009 May;13(2):267-75. doi: 10.1016/j.cld.2009.02.003.
9
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.托吡酯治疗对酒精依赖个体身体健康和生活质量的改善：美国多中心随机对照试验。
Arch Intern Med. 2008 Jun 9;168(11):1188-99. doi: 10.1001/archinte.168.11.1188.
10
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.酒精依赖的联合药物治疗与行为干预：综合疗法研究：一项随机对照试验
JAMA. 2006 May 3;295(17):2003-17. doi: 10.1001/jama.295.17.2003.
Zotero 插件